Revaccination with COVID-19 Vaccines after Anaphylaxis
Organization: Public Health Agency of Canada (PHAC)Published: 2021
November 15, 2021
Duration: 30 minutes
Presentation highlights:
- Explain the October 22nd, 2021 guidance from the National Advisory Committee on Immunization regarding reimmunization of people with previous severe immediate allergic reactions (anaphylaxis) following COVID-19 vaccines or to their components or container.
- Examine the evidence and rationale behind the recommendations.
- Locate resources to facilitate safe immunization or reimmunization of people with severe immediate allergic reactions (anaphylaxis) following COVID-19 vaccines or to their components.
Moderator:
- Stephanie Elliott, MPH, CPH, Public Health Agency of Canada
Speaker:
- Dr. Elissa Abrams, MD, MPH, FRCPC, Public Health Agency of Canada
Slides Available: Click Here
Product Type:
Webinar
Category:
Audience:
Health Care Professional
Region: National
Region: National
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.